01 4Bayer Inc.
02 1Bayer Inc., Healthcare Division
01 42309332
02 12599617
01 5Vardenafil Hydrochloride
01 2Disintegrating Tablet
02 3Tablet
01 42018-10-31
02 12026-02-16
Patent Expiration Date : 2018-10-31
Date Granted : 2002-12-03
Brand Name : LEVITRA
Patent Number : 2309332
Filing Date : 1998-10-31
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-10-31
Date Granted : 2002-12-03
Patent Expiration Date : 2018-10-31
Date Granted : 2002-12-03
Brand Name : LEVITRA
Patent Number : 2309332
Filing Date : 1998-10-31
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-10-31
Date Granted : 2002-12-03
Patent Expiration Date : 2018-10-31
Date Granted : 2002-12-03
Brand Name : LEVITRA
Patent Number : 2309332
Filing Date : 1998-10-31
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-10-31
Date Granted : 2002-12-03
Patent Expiration Date : 2018-10-31
Date Granted : 2002-12-03
Brand Name : STAXYN
Patent Number : 2309332
Filing Date : 1998-10-31
Strength per Unit : 10 mg
Dosage Form : Disintegrating Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-10-31
Date Granted : 2002-12-03
Patent Expiration Date : 2026-02-16
Date Granted : 2012-01-10
Brand Name : STAXYN
Patent Number : 2599617
Filing Date : 2006-02-16
Strength per Unit : 10 mg
Dosage Form : Disintegrating Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-02-16
Date Granted : 2012-01-10
LOOKING FOR A SUPPLIER?
